Skip to main content
SpringerLink
Log in

Diabetic Retinopathy and Systemic Complications

  • Chapter
Diabetic Retinopathy

Part of the book series: Contemporary Diabetes ((CDI))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Frank RN. Diabetic retinopathy. N Engl J Med 2004350(1):48–58

    PubMed  CAS  Google Scholar 

  2. Wong TY, Klein R, Klein BE, Tielsch JM, Hubbard L, Nieto FJ. Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol 200146(1):59–80

    PubMed  CAS  Google Scholar 

  3. Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med 2004351(22):2310–7

    PubMed  CAS  Google Scholar 

  4. Wong T Y, McIntosh R. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull 200573–74:57–70

    PubMed  Google Scholar 

  5. Wong TY, McIntosh R. Systemic associations of retinal microvascular signs: A review of recent population-based studies. Ophthalmic Physiol Opt 200525(3):195–204

    PubMed  Google Scholar 

  6. St Clair L, Ballantyne CM. Biological surrogates for enhancing cardiovascular risk prediction in type 2 diabetes mellitus. Am J Cardiol 200799(4A):80B–88B

    PubMed  Google Scholar 

  7. Nguyen TT, Wong TY. Retinal vascular manifestations of metabolic disorders. Trends EndocrinolMetab 200617(7):262–8

    CAS  Google Scholar 

  8. Cheung N, Wong TY. Retinal vascular changes as biomarkers of systemic cardiovascular diseases. In: Jelinek Hand Cree M (eds). Automated image detection of retinal pathology (In press)

    Google Scholar 

  9. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 1999117(11):1487–95

    PubMed  CAS  Google Scholar 

  10. Van Hecke M V, Dekker JM, Nijpels G, et al. Retinopathy is associated with cardiovascular and all-cause mortality in both diabetic and nondiabetic subjects: The hoorn study. Diabetes Care 200326(10):2958

    PubMed  Google Scholar 

  11. Henricsson M, Nilsson A, Heijl A, Janzon L, Groop L. Mortality in diabetic patients participating in an ophthalmological control and screening programme. Diabet Med 199714(7):576–83

    PubMed  CAS  Google Scholar 

  12. Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care 200730(2):292–9

    PubMed  Google Scholar 

  13. Rajala U, Pajunpaa H, Koskela P, Keinanen-Kiukaanniemi S. High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy. Diabetes Care 200023(7):957–61

    PubMed  CAS  Google Scholar 

  14. Cusick M, Meleth AD, Agron E, et al. Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: Early treatment diabetic retinopathy study report no. 27. Diabetes Care 200528(3):617–25

    PubMed  Google Scholar 

  15. Sasaki A, Uehara M, Horiuchi N, Hasegawa K, Shimizu T. A 15-year follow-up study of patients with non-insulin-dependent diabetes mellitus (NIDDM) in Osaka, Japan. Factors predictive of the prognosis of diabetic patients. Diabetes Res Clin Pract 199736(1):41–7

    PubMed  CAS  Google Scholar 

  16. Hanis CL, Chu HH, Lawson K, et al. Mortality of Mexican Americans with NIDDM. Retinopathy and other predictors in Starr County, Texas. Diabetes Care 199316(1):82–9

    PubMed  CAS  Google Scholar 

  17. Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care 199215(12):1875–91

    PubMed  CAS  Google Scholar 

  18. van Hecke MV, Dekker JM, Stehouwer CD, et al. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: The EURODIAB prospective complications study. Diabetes Care 200528(6):1383–9

    PubMed  Google Scholar 

  19. Torffvit O, Lovestam-Adrian M, Agardh E, Agardh CD. Nephropathy, but not retinopathy, is associated with the development of heart disease in Type 1 diabetes: A 12-year observation study of 462 patients. Diabet Med 200522(6):723–9

    PubMed  CAS  Google Scholar 

  20. Klein BE, Klein R, McBride PE, et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 2004164(17):1917–24

    PubMed  Google Scholar 

  21. Fuller JH, Stevens LK, Wang SL. Risk factors for cardiovascular mortality and morbidity: The WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 200144(Suppl 2):S54–64

    PubMed  CAS  Google Scholar 

  22. Targher G, Bertolini L, Tessari R, Zenari L, Arcaro G. Retinopathy predicts future cardiovascular events among type 2 diabetic patients: The Valpolicella Heart Diabetes Study. Diabetes Care 200629(5):1178

    PubMed  Google Scholar 

  23. Klein R, Marino EK, Kuller LH, et al. The relation of atherosclerotic cardiovascular disease to retin-opathy in people with diabetes in the Cardiovascular Health Study. Br J Ophthalmol 200286(1):84–90

    PubMed  Google Scholar 

  24. Jager A, van Hinsbergh VW, Kostense PJ, et al. Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria. Nephrol Dial Transplant 200116(3):529–36

    PubMed  CAS  Google Scholar 

  25. Greenberg SM. Small vessels, big problems. N Engl J Med 2006354(14):1451–3

    PubMed  CAS  Google Scholar 

  26. Alex M, Baron EK, Goldenberg S, Blumenthal HT. An autopsy study of cerebrovascular accident in diabetes mellitus. Circulation 196225:663–73

    PubMed  CAS  Google Scholar 

  27. Aronson SM. Intracranial vascular lesions in patients with diabetes mellitus. J Neuropathol Exp Neurol 197332(2):183–96

    PubMed  CAS  Google Scholar 

  28. Bell DS. Stroke in the diabetic patient. Diabetes Care 199417(3):213–9

    PubMed  CAS  Google Scholar 

  29. Wong T Y. Is retinal photography useful in the measurement of Stroke risk? Lancet Neurol 20043(3):179–83

    PubMed  Google Scholar 

  30. Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ, Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: A rationale based on homology between cerebral and retinal microvasculatures. J Anat 2005206(4):319–48

    PubMed  Google Scholar 

  31. Okada H, Horibe H, Yoshiyuki O, Hayakawa N, Aoki N. A prospective study of cerebrovascular disease in Japanese rural communities, Akabane and Asahi. Part 1: Evaluation of risk factors in the occurrence of cerebral hemorrhage and thrombosis. Stroke 19767(6):599–607

    PubMed  CAS  Google Scholar 

  32. Tanaka H, Hayashi M, Date C, et al. Epidemiologic studies of Stroke in Shibata, a Japanese provincial city: Preliminary report on risk factors for cerebral infarction. Stroke 198516(5):773–80

    PubMed  CAS  Google Scholar 

  33. Svardsudd K, Wedel H, Aurell E, Tibblin G. Hypertensive eye ground changes. Prevalence, relation to blood pressure and prognostic importance. The study of men born in 1913. Acta Med Scand 1978204(3):159–67

    PubMed  CAS  Google Scholar 

  34. Nakayama T, Date C, Yokoyama T, Yoshiike N, Yamaguchi M, Tanaka H. A 15.5-year follow-up study of Stroke in a Japanese provincial city. The Shibata Study. Stroke 199728(1):45–52

    PubMed  CAS  Google Scholar 

  35. Goto I, Katsuki S, Ikui H, Kimoto K, Mimatsu T. Pathological studies on the intracerebral and retinal arteries in cerebrovascular and noncerebrovascular diseases. Stroke 19756(3):263–9

    PubMed  CAS  Google Scholar 

  36. Schneider R, Rademacher M, Wolf S. Lacunar infarcts and white matter attenuation. Ophthalmologic and microcirculatory aspects of the pathophysiology. Stroke 199324(12):1874–9

    PubMed  CAS  Google Scholar 

  37. Petitti DB, Bhatt H. Retinopathy as a risk factor for nonembolic Stroke in diabetic subjects. Stroke 199526(4):593–6

    PubMed  CAS  Google Scholar 

  38. Cheung N, Rogers S, Couper DJ, Klein R, Sharrett AR, Wong T Y. Is diabetic retinopathy an independent risk factor for ischemic Stroke? Stroke 200638(2):398–401

    PubMed  Google Scholar 

  39. Wong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident Stroke: The Atherosclerosis Risk in Communities Study. Lancet 2001358(9288):1134–40

    PubMed  CAS  Google Scholar 

  40. Wong T Y, Klein R, Sharrett AR, et al. Cerebral white matter lesions, retinopathy, and incident clinical Stroke. J Am Med Assoc 2002288(1):67–74

    Google Scholar 

  41. Wong T Y, Klein R, Sharrett AR, et al. The prevalence and risk factors of retinal microvascular abnormalities in older persons: The Cardiovascular Health Study. Ophthalmology 2003110(4):658–66

    PubMed  Google Scholar 

  42. Wong T Y, Klein R, Nieto FJ, et al. Retinal microvascular abnormalities and 10-year cardiovascular mortality: A population-based case—control study. Ophthalmology 2003110(5):933–40

    PubMed  Google Scholar 

  43. Mitchell P, Wang JJ, Wong TY, Smith W, Klein R, Leeder SR. Retinal microvascular signs and risk of Stroke and Stroke mortality. Neurology 200565(7):1005–9

    PubMed  CAS  Google Scholar 

  44. Wong T Y, Barr EL, Tapp RJ, et al. Retinopathy in persons with impaired glucose metabolism: The Australian Diabetes Obesity and Lifestyle (AusDiab) study. Am J Ophthalmol 2005140(6):1157–9

    PubMed  CAS  Google Scholar 

  45. Wong T Y, Klein R, Sharrett AR, et al. Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: The Atherosclerosis Risk in Communities Study. Stroke 200233(6):1487–92

    PubMed  Google Scholar 

  46. Wong TY, Mosley TH, Jr., Klein R, et al. Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people. Neurology 200361(6):806–11

    PubMed  CAS  Google Scholar 

  47. Tekin O, Cukur S, Uraldi C, et al. Relationship between retinopathy and cognitive impairment among hypertensive subjects. A case—control study in the ankara-pursaklar region. Eur Neurol 200452(3):156–61

    PubMed  Google Scholar 

  48. Baker ML, Larsen EK, Kuller LH, et al. Retinal microvascular signs, cognitive function, and dementia in older persons. The Cardiovascular Health Study. Stroke 200738:2041

    PubMed  Google Scholar 

  49. Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood—brain barrier responsible for lacunar Stroke, leukoaraiosis, and dementia? Stroke 200334(3):806–12

    PubMed  CAS  Google Scholar 

  50. Duran JR, 3rd, Taffet G. Coronary microvascular dysfunction. N Engl J Med 2007356(22):2324–5; author reply 2325

    PubMed  CAS  Google Scholar 

  51. Factor SM, Okun EM, Minase T. Capillary microaneurysms in the human diabetic heart. N Engl J Med 1980302(7):384–8

    PubMed  CAS  Google Scholar 

  52. Di Carli MF, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 200341(8):1387–93

    PubMed  Google Scholar 

  53. Miura H, Wachtel RE, Loberiza FR, Jr., et al. Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: Reduced activity of ATP-sensitive potassium channels. Circ Res 200392(2):151–8

    PubMed  CAS  Google Scholar 

  54. Li Q, Wang J, Sun Y, et al. Efficacy of postoperative transarterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma complicated by portal vein tumor thrombosis — a randomized study. World J Surg 200630(11):2004–11; discussion 2012–3

    PubMed  CAS  Google Scholar 

  55. Pitkanen OP, Nuutila P, Raitakari OT, et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes 199847(2):248–54

    PubMed  CAS  Google Scholar 

  56. Hiller R, Sperduto RD, Podgor MJ, Ferris FL, 3rd, Wilson PW. Diabetic retinopathy and cardiovascular disease in type II diabetics. The Framingham Heart Study and the Framingham Eye Study. Am J Epidemiol 1988128(2):402–9

    PubMed  CAS  Google Scholar 

  57. Breslin DJ, Gifford RW, Jr., Fairbairn JF, 2nd, Kearns TP. Prognostic importance of ophthalmoscopic findings in essential hypertension. J Am Med Assoc 1966195(5):335–8

    CAS  Google Scholar 

  58. Breslin DJ, Gifford RW, Jr., Fairbairn JF, 2nd. Essential hypertension. A twenty-year follow-up study. Circulation 196633(1):87–97

    PubMed  CAS  Google Scholar 

  59. Michelson EL, Morganroth J, Nichols CW, MacVaugh H, 3rd. Retinal arteriolar changes as an indicator of coronary artery disease. Arch Intern Med 1979139(10):1139–41

    PubMed  CAS  Google Scholar 

  60. Duncan BB, Wong T Y, Tyroler HA, Davis CE, Fuchs FD. Hypertensive retinopathy and incident coronary heart disease in high risk men. Br J Ophthalmol 200286(9):1002–6

    PubMed  CAS  Google Scholar 

  61. Cheung N, Wang JJ, Klein R, Couper DJ, Richey Sharrett AR, Wong T Y. diabetic retinopathy and the risk of coronary heart disease: The Atherosclerosis risk in communities study. Diabetes Care 200730:1742–6

    PubMed  Google Scholar 

  62. Wong T Y, Rosamond W, Chang PP, et al. Retinopathy and risk of congestive heart failure. J Am Med Assoc 2005293(1):63–9

    CAS  Google Scholar 

  63. Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Retinopathy predicts coronary heart disease events in NIDDM patients. Diabetes Care 199619(12):1445–8

    PubMed  CAS  Google Scholar 

  64. Faglia E, Favales F, Calia P, et al. Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care 200225(11):2032–6

    Google Scholar 

  65. Soedamah-Muthu SS, Chaturvedi N, Toeller M, et al. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: The EURODIAB Prospective Complications Study. Diabetes Care 200427(2):530–7

    PubMed  Google Scholar 

  66. Araz M, Celen Z, Akdemir I, Okan V. Frequency of silent myocardial ischemia in type 2 diabetic patients and the relation with poor glycemic control. Acta Diabetol 200441(2):38–43

    PubMed  CAS  Google Scholar 

  67. Gokcel A, Aydin M, Yalcin F, et al. Silent coronary artery disease in patients with type 2 Diabetes mel-litus. Acta Diabetol 200340(4):176–80

    PubMed  CAS  Google Scholar 

  68. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V. Silent myocardial ischemia in patients with Diabetes: Who to screen. Diabetes Care 199922(9):1396–400

    PubMed  CAS  Google Scholar 

  69. Naka M, Hiramatsu K, Aizawa T, et al. Silent myocardial ischemia in patients with non-insulin-dependent Diabetes mellitus as judged by treadmill exercise testing and coronary angiography. 1992123(1):46–53

    CAS  Google Scholar 

  70. Norgaz T, Hobikoglu G, Aksu H, et al. Retinopathy is related to the angiographically detected severity and extent of coronary artery disease in patients with type 2 Diabetes mellitus. Int Heart J 200546(4):639–46

    PubMed  Google Scholar 

  71. Yoon JK, Lee KH, Park JM, et al. Usefulness of diabetic retinopathy as a marker of risk for thallium myo-cardial perfusion defects in non-insulin-dependent Diabetes mellitus. Am J Cardiol 200187(4):456–9, A6

    PubMed  CAS  Google Scholar 

  72. Briguori C, Condorelli G, Airoldi F, et al. Impact of microvascular complications on outcome after coronary stent implantations in patients with Diabetes. J Am Coll Cardiol 200545(3):464–6

    PubMed  Google Scholar 

  73. Kim YH, Hong MK, Song JM, et al. Diabetic retinopathy as a predictor of late clinical events following percutaneous coronary intervention. J Invasive Cardiol 200214(10):599–602

    PubMed  Google Scholar 

  74. Ono T, Kobayashi J, Sasako Y, et al. The impact of diabetic retinopathy on long-term outcome following coronary artery bypass graft surgery. J Am Coll Cardiol 200240(3):428–36

    PubMed  Google Scholar 

  75. Ono T, Ohashi T, Asakura T, et al. Impact of diabetic retinopathy on cardiac outcome after coronary artery bypass graft surgery: Prospective observational study. Ann Thorac Surg 200681(2):608–12

    PubMed  Google Scholar 

  76. Ohno T, Ando J, Ono M, et al. The beneficial effect of coronary-artery-bypass surgery on survival in patients with diabetic retinopathy. Eur J Cardiothorac Surg 200630(6):881–6

    PubMed  Google Scholar 

  77. Giugliano D, Acampora R, De Rosa N, et al. Coronary artery disease in type-2 Diabetes mellitus: A scintigraphic study. Diabete Metab 199319(5):463–6

    PubMed  CAS  Google Scholar 

  78. Ioannidis G, Peppa M, Rontogianni P, et al. The concurrence of microalbuminuria and retinopathy with cardiovascular risk factors; reliable predictors of asymptomatic coronary artery disease in type 2 Diabetes. Hormones(Athens) 20043(3):198–203

    Google Scholar 

  79. Akasaka T, Yoshida K, Hozumi T, et al. Retinopathy identifies marked restriction of coronary flow reserve in patients with Diabetes mellitus. J Am Coll Cardiol 199730(4):935–41

    PubMed  CAS  Google Scholar 

  80. Celik T, Berdan ME, Iyisoy A, et al. Impaired coronary collateral vessel development in patients with proliferative diabetic retinopathy. Clin Cardiol 200528(8):384–8

    PubMed  Google Scholar 

  81. Yoshida M, Takamatsu J, Yoshida S, et al. Scores of coronary calcification determined by electron beam computed tomography are closely related to the extent of Diabetes-specific complications. Horm Metab Res 199931(10):558–63

    PubMed  CAS  Google Scholar 

  82. Nag S, Robertson DM, Dinsdale HB. Morphological changes in spontaneously hypertensive rats. Acta Neuropathol(Berl) 198052(1):27–34

    CAS  Google Scholar 

  83. Chavers BM, Mauer SM, Ramsay RC, Steffes MW. Relationship between retinal and glomerular lesions in IDDM patients. Diabetes 199443(3):441–6

    PubMed  CAS  Google Scholar 

  84. Pontremoli R, Cheli V, Sofia A, et al. Prevalence of micro- and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension. Nephrol Dial Transplant 199510(Suppl 6):6–9

    PubMed  Google Scholar 

  85. Klein R, Klein BE, Moss SE, Cruickshanks KJ, Brazy PC. The 10-year incidence of renal insufficiency in people with type 1 Diabetes. Diabetes Care 199922(5):743–51

    PubMed  CAS  Google Scholar 

  86. Wong T Y, Coresh J, Klein R, et al. Retinal microvascular abnormalities and renal dysfunction: The atherosclerosis risk in communities study. J Am Soc Nephrol 200415(9):2469–76

    PubMed  Google Scholar 

  87. Edwards MS, Wilson DB, Craven TE, et al. Associations between retinal microvascular abnormalities and declining renal function in the elderly population: The Cardiovascular Health Study. Am J Kidney Dis 200546(2):214–24

    PubMed  Google Scholar 

  88. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ, 3rd, O'Brien PC. Risk factors for severity of diabetic polyneuropathy: Intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 199922(9):1479–86

    PubMed  CAS  Google Scholar 

  89. Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care 199619(11):1243–8

    PubMed  CAS  Google Scholar 

  90. Barr EL, Wong T Y, Tapp RJ, et al. Is peripheral neuropathy associated with retinopathy and albuminu-ria in individuals with impaired glucose metabolism? The 1999–2000 AusDiab. Diabetes Care 200629(5):1114–6

    PubMed  Google Scholar 

  91. Rema M, Mohan V, Deepa R, Ravikumar R. Association of carotid intima-media thickness and arterial stiffness with diabetic retinopathy: The Chennai Urban Rural Epidemiology Study (CURES-2). Diabetes Care 200427(8):1962–7

    PubMed  Google Scholar 

  92. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation 2006114(6):597–605

    PubMed  CAS  Google Scholar 

  93. Parving HH, Nielsen FS, Bang LE, et al. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy. Diabetologia 199639(12):1590–7

    PubMed  CAS  Google Scholar 

  94. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 198932(4):219–26

    PubMed  CAS  Google Scholar 

  95. Brindle P, May M, Gill P, et al. Primary prevention of cardiovascular disease: A web-based risk score for seven British black and minority ethnic groups. Heart 200692(11):1595–602

    PubMed  CAS  Google Scholar 

  96. Stephens JW, Ambler G, Vallance P, Betteridge DJ, Humphries SE, Hurel SJ. Cardiovascular risk and Diabetes. Are the methods of risk prediction satisfactory? Eur J Cardiovasc Prev Rehabil 200411(6):521–8

    PubMed  Google Scholar 

  97. Guzder RN, Gatling W, Mullee MA, Mehta RL, Byrne CD. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 Diabetes: Results from a United Kingdom study. Diabet Med 200522(5):554–62

    PubMed  CAS  Google Scholar 

  98. Lee ET, Howard B V, Wang W, et al. Prediction of coronary heart disease in a population with high prevalence of Diabetes and albuminuria: The Strong Heart Study. Circulation 2006113(25):2897–905

    PubMed  Google Scholar 

  99. Donnan PT, Donnelly L, New JP, Morris AD. Derivation and validation of a prediction score for major coronary heart disease events in a U.K. Type 2 diabetic population. Diabetes Care 200629(6):1231–6

    PubMed  Google Scholar 

  100. Wong T Y, Klein R, Klein BEK. The epidemiology of diabetic retinopathy. In: Scott I, Harry Flynn H, Smiddy W (eds). Diabetic Retinopathy. Oxford University Press (In press)

    Google Scholar 

  101. Wong T Y, Klein R. The epidemiology of eye diseases in Diabetes. In: Ekoe JM, Zimmet P, Williams R, Rewers M (eds). The Epidemiology of Diabetes Mellitus. John Wiley and Sons (In press)

    Google Scholar 

  102. Cugati S, Cikamatana L, Wang JJ, Kifley A, Liew G, Mitchell P. Five-year incidence and progression of vascular retinopathy in persons without Diabetes: The Blue Mountains Eye Study. Eye 200620(11):1239–45

    PubMed  CAS  Google Scholar 

  103. Klein R, Klein BE, Moss SE. The relation of systemic hypertension to changes in the retinal vascula-ture: The Beaver Dam Eye Study. Trans Am Ophthalmo Soc 1997;95:329–48; discussion 348–50

    CAS  Google Scholar 

  104. Cooper LS, Wong TY, Klein R, et al. Retinal microvascular abnormalities and MRI-defined subclini-cal cerebral infarction: The Atherosclerosis Risk in Communities Study. Stroke 2006;37(1):82–6

    PubMed  Google Scholar 

  105. Hirai FE, Moss SE, Knudtson MD, Klein BE, Klein R. Retinopathy and survival in a population without Diabetes: The Beaver Dam Eye Study. Am J Epidemiol 2007;166(6):724–30

    PubMed  Google Scholar 

  106. Klein R, Klein BE, Moss SE, Wong TY. The relationship of retinopathy in persons without Diabetes to the 15-year incidence of Diabetes and hypertension: Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2006;104:98–107

    PubMed  Google Scholar 

  107. Wong TY, Mohamed Q, Klein R, Couper DJ. Do retinopathy signs in non-diabetic individuals predict the subsequent risk of Diabetes? Br J Ophthalmol 2006;90(3):301–3

    PubMed  CAS  Google Scholar 

  108. Cugati S, Mitchell P, Wang JJ. Do retinopathy signs in non-diabetic individuals predict the subsequent risk of Diabetes? Br J Ophthalmol 2006;90(7):928–9

    PubMed  CAS  Google Scholar 

  109. Hubbard LD, Brothers RJ, King WN, et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 1999;106(12):2269–80

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Eye Research Australia, The University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne

    Ning Cheung & Tien Y. Wong

Authors
  1. Ning Cheung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tien Y. Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Elia J. Duh MD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, Springer Science + Business Media, LLC

About this chapter

Cite this chapter

Cheung, N., Wong, T.Y. (2008). Diabetic Retinopathy and Systemic Complications. In: Duh, E.J. (eds) Diabetic Retinopathy. Contemporary Diabetes. Humana Press. https://doi.org/10.1007/978-1-59745-563-3_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-563-3_21

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-934115-83-1

  • Online ISBN: 978-1-59745-563-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation